In fact, CypD plays a key role in ischemia–reperfusion injury, atherosclerosis, and diabetes [63–65], and regulates the pore to face a high-fat diet treatment causing mitochondrial dysfunction and insulin resistance [66, 67]. This evidence concerns the gene INS and atherosclerosis.